While clinicians attending the American Society of Hematology meeting in Atlanta this weekend were anticipating a flurry of exciting data, the conference wasn’t entirely prepared for the ac
Gene therapy company Spark Therapeutics has published data showing its one-time treatment can almost entirely eliminate bleeds in patients with haemophilia B.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
